Digital Guide: PARP Inhibitors for Ovarian Cancer - San Jose

Dr. John Chan's guide to treating ovarian cancer with PARP inhibitors

×

Welcome to Dr. John Chan’s guide to understanding the use of PARP inhibitors for ovarian cancer.

Dr. Chan, of Sutter Bay Medical Foundation, has collaborated with SurvivorNet for this resource. People in the ovarian cancer community tell us that hearing advice like this, and knowing the options, has helped them make better decisions and reduce anxiety.

Dr. John Chan Sutter Bay Medical Foundation

Your Digital Guide begins below: 3 Chapters / 3 Video Segments

What are PARP Inhibitors? (1)
1. PARP Inhibitors for Ovarian Cancer

Dr. John Chan

PARP inhibitors are proving to be an important ally in the battle against ovarian cancer, particularly among patients with a BRCA1 or BRCA2 mutation

Niraparib (1)
2. Niraparib for Ovarian Cancer Treatment

Dr. John Chan

One PARP inhibitor, in particular, Niraparib, has shown promise in the battle against ovarian cancer, regardless of whether patients carry a BRCA mutation

Side Effects (1)
3. Coping With PARP Inhibitor Side Effects

Dr. John Chan

Since PARP inhibitors disrupt how cells repair damaged DNA, killing off tumor cells and healthy cells simultaneously, fatigue, bone marrow suppression and nausea may occur.

×

Get SurvivorNet in Your Inbox

Our newsletter – vital information, hope, and healing, delivered weekly.

Never want to see this again? Click here to dismiss this module permanently.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.